Company / SG&A per Share
Prime Medicine, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.40
FY2025
5-year range
$0.40 / $1.07
FY2021-FY2025
Trend
-10.4%
vs FY2024
Sector context
#179 of 210
Health Care
What the data says
Prime Medicine, Inc.'s sg&a per share of $0.40 is lower than 85% of companies in the Health Care sector (FY2025). SG&A per Share has declined for 5 consecutive years, from $1.20 in FY2020 to $0.40 in FY2025.
Based on SEC 10-K filings.
0.40 in FY2025 with a 5-year CAGR of -19.7%.
Improved from $0.48 to $0.40 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -24.3%
- 5-Year CAGR
- -19.7%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 210This company $0.40 Sector average $40.75
▼
-99.0% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s sg&a per share has declined for 5 consecutive years.
- In FY2025, sg&a per share decreased 10.4% year-over-year.
- Ranks #179 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | -10.4% |
| FY2024 | $0.45 | -6.6% |
| FY2023 | $0.48 | -48.2% |
| FY2022 | $0.92 | -14.3% |
| FY2021 | $1.07 | -10.4% |
| FY2020 | $1.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026